Ascendis Pharma
ASND
$136.93
Share price
-4.37%
Change (1 day)
74.74%
Change (1 year)
Categories
Revenue for Ascendis Pharma (ASND)
Revenue in 2023 (TTM): $0.29 B
According to Ascendis Pharma 's latest financial reports the company's current revenue (TTM) is $0.29 B. In 2022 the company made a revenue of $53.6 M an increase over the years 2021 revenue that were of $8.92 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Ascendis Pharma from 2014 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.29 B | 443.07% |
| 2022 | $53.6 M | 500.43% |
| 2021 | $8.92 M | 12.1% |
| 2020 | $7.96 M | -46.86% |
| 2019 | $14.98 M | 23.79% |
| 2018 | $12.1 M | 590.24% |
| 2017 | $1.75 M | -65.6% |
| 2016 | $5.09 M | -43.21% |
| 2015 | $8.97 M | -51.18% |
| 2014 | $18.39 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Akebia Therapeutics AKBA | $0.19 B | -33.11% | 🇺🇸 USA |
 Affimed
AFMD | $8.95 M | -96.92% | 🇩🇪 Germany |
 Advaxis ADXS | $0.13 M | -99.95% | 🇺🇸 USA |